Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Jarl

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Environmental Research and Public Health|January 31, 2017
Are There Inequities in Treatment of End-Stage Renal Disease in Sweden? A Longitudinal Register-Based Study on Socioeconomic Status-Related Access to Kidney TransplantationYe Zhang, Johan Jarl, Ulf-G Gerdtham
International Journal for Equity in Health|February 11, 2011
Equalisation of alcohol participation among socioeconomic groups over time: an analysis based on the total differential approach and longitudinal data from SwedenJean-Baptiste Combes, Ulf-Göran Gerdtham, Johan Jarl
BMC Health Services Research|November 9, 2018
Effects of a multifaceted intervention QI program to improve ICU performanceAnders Ersson, Anders Beckman, Johan Jarl, et al.
Developmental Medicine and Child Neurology|September 20, 2020
Prevalence of pain and interference with daily activities and sleep in adults with cerebral palsyElisabet Rodby-Bousquet, Ann Alriksson-Schmidt, Johan Jarl
Disability and Health Journal|March 7, 2019
Health-related quality of life in adults with cerebral palsy living in Sweden and relation to demographic and disability-specific factorsJohan Jarl, Ann Alriksson-Schmidt, Elisabet Rodby-Bousquet
Cost Effectiveness and Resource Allocation : C/E|October 27, 2009
Medical net cost of low alcohol consumption - a cause to reconsider improved health as the link between alcohol and wage?Johan Jarl, Ulf G Gerdtham, Klara Hradilova Selin
Health and Quality of Life Outcomes|July 10, 2025
Comparison of the measurement properties of EQ-5D-5L and SF-6Dv2 in Chinese patients on dialysisYe Zhang, Zeyuan Chen, Li Yang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 22, 2025
Cost-Effectiveness of Interventions Addressing Loneliness Among Adults: A Systematic Literature ReviewAnnette Bertolino, Johan Jarl, Ulf Gerdtham, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 9, 2024
Is the shift in treatment patterns towards new, more expensive drugs still driving the increase in pharmaceutical expenditure? A decomposition analysis of expenditure data in Sweden 1990-2022Marie-Catherine Schaller, Ulf-G Gerdtham, Johan Jarl
Movement Disorders Clinical Practice|May 8, 2019
Economic Evaluation of Interventions in Parkinson's Disease: A Systematic Literature ReviewNafsika Afentou, Johan Jarl, Ulf-G Gerdtham, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Environmental Research and Public Health|January 31, 2017
Are There Inequities in Treatment of End-Stage Renal Disease in Sweden? A Longitudinal Register-Based Study on Socioeconomic Status-Related Access to Kidney TransplantationYe Zhang, Johan Jarl, Ulf-G Gerdtham
International Journal for Equity in Health|February 11, 2011
Equalisation of alcohol participation among socioeconomic groups over time: an analysis based on the total differential approach and longitudinal data from SwedenJean-Baptiste Combes, Ulf-Göran Gerdtham, Johan Jarl
BMC Health Services Research|November 9, 2018
Effects of a multifaceted intervention QI program to improve ICU performanceAnders Ersson, Anders Beckman, Johan Jarl, et al.
Developmental Medicine and Child Neurology|September 20, 2020
Prevalence of pain and interference with daily activities and sleep in adults with cerebral palsyElisabet Rodby-Bousquet, Ann Alriksson-Schmidt, Johan Jarl
Disability and Health Journal|March 7, 2019
Health-related quality of life in adults with cerebral palsy living in Sweden and relation to demographic and disability-specific factorsJohan Jarl, Ann Alriksson-Schmidt, Elisabet Rodby-Bousquet
Cost Effectiveness and Resource Allocation : C/E|October 27, 2009
Medical net cost of low alcohol consumption - a cause to reconsider improved health as the link between alcohol and wage?Johan Jarl, Ulf G Gerdtham, Klara Hradilova Selin
Health and Quality of Life Outcomes|July 10, 2025
Comparison of the measurement properties of EQ-5D-5L and SF-6Dv2 in Chinese patients on dialysisYe Zhang, Zeyuan Chen, Li Yang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 22, 2025
Cost-Effectiveness of Interventions Addressing Loneliness Among Adults: A Systematic Literature ReviewAnnette Bertolino, Johan Jarl, Ulf Gerdtham, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 9, 2024
Is the shift in treatment patterns towards new, more expensive drugs still driving the increase in pharmaceutical expenditure? A decomposition analysis of expenditure data in Sweden 1990-2022Marie-Catherine Schaller, Ulf-G Gerdtham, Johan Jarl
Movement Disorders Clinical Practice|May 8, 2019
Economic Evaluation of Interventions in Parkinson's Disease: A Systematic Literature ReviewNafsika Afentou, Johan Jarl, Ulf-G Gerdtham, et al.
Pageof 7